Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001415889-24-013504

SVP, FINANCE, CHIEF ACCT OFFCR sold 30,837 shares at an average $42.30 ($1,304,435)

  • SVP, FINANCE, CHIEF ACCT OFFCR acquired 28,872 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Young Joseph R · SVP, FINANCE, CHIEF ACCT OFFCR

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-15 Exercise or conversion : show line 1 in the form +8,221 $3.94 $32,387 61,392 D
2024-05-15 Sale : show line 2 in the form −8,221 $42.17 $346,680 53,171 D
2024-05-15 Sale : show line 3 in the form −1,965 $42.68 $83,866 51,206 D
2024-05-16 Exercise or conversion : show line 4 in the form +18,151 $7.87 $142,848 69,357 D
2024-05-16 Sale : show line 5 in the form −18,151 $42.22 $766,317 51,206 D
2024-05-16 Exercise or conversion : show line 6 in the form +2,500 $7.87 $19,675 53,706 D
2024-05-16 Sale : show line 7 in the form −2,500 $43.03 $107,573 51,206 D
Open-market sales · 30,837 sh · avg $42.30 · $1,304,435

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-05-15 Exercise or conversion : show line 8 in the form Stock Option (right to buy) −8,221 58,589 D
2024-05-16 Exercise or conversion : show line 9 in the form Stock Option (right to buy) −20,651 69,349 D
Loading xslF345X05/form4-05172024_080555.xml…